期刊文献+

连续性血液净化在心脏手术后急性少尿型肾衰中的应用 被引量:2

Continuous blood purification treatment of oliguric acute renal failure after heart surgery
下载PDF
导出
摘要 目的探讨连续性血液净化(CBP)在治疗心脏手术后急性少尿型肾衰竭中的效果。方法将27例心脏手术后急性少尿型肾衰竭伴血流动力学不稳定、低血压休克患者分为存活组(A组,n=14)和死亡组(B组,n=13),比较CBP治疗前及治疗后12、24、48 h两组APACHEⅡ-评分、血气分析指标、平均动脉压、肾功能、血管活性药使用情况。结果(1)A组和B组CBP治疗后各项检测指标与治疗前比较均有一定差异,A组效果更佳。(2)CBP治疗后A组的平均动脉压及升压药用量变化与治疗前比较差异有统计学意义,B组则差异无统计学意义。(3)A、B组之间APACH-Ⅱ评分、器官衰竭数目及CBP治疗距急性肾衰竭(ARF)诊断的时间差异有统计学意义(均P<0.05)。结论CBP是治疗心脏术后急性少尿型肾衰的有效方法,它有助于维持患者的内环境、纠正血流动力学不稳定状态,ARF合并其他器官衰竭者早期行CBP治疗是降低死亡率的关键措施。 Objective To study the efficacy of continuous blood purification(CBP) treatment on oliguric acute renal failure(OARF) after heart surgery.Methods Twenty-seven patients were divided into two groups:group A(consisting of 14 surviving patients) and group B(consisting of 13 deceased patients),all of them had undergone an OARF after heart surgery and treated by CBP.We compared the differnce of APACHE-Ⅱ marks,blood gas indexes,mean artery pressure,renal function as well as usage of vasoactive drugs preceding to and 12,24,48h after heart surgery in these two groups.Results(1) After CBP treatment,analysis indexes of both groups had improved with group A improving more.(2) After CBP treatment,there was a significant improvement in group A in mean artery pressure and pressor dosage while no significant improvement was found in group B.(3) There was a significant difference between group A and group B in APACH-Ⅱ marks,organ failure and the time gap between ARF diagnosis and CBP treatment(P<0.05).Conclusions CBP is an effective means to treat OARF after heart surgery,by maintaining the patients′ internal condition and remedying hemodynamic instability.Early CBP treatment for ARF is a key method to reduce the mortality.
出处 《现代医学》 2007年第6期444-447,共4页 Modern Medical Journal
关键词 连续性血液净化 急性少尿型肾衰竭 心脏手术 continuous blood purification oliguric acute renal failure heart surgery
  • 相关文献

参考文献11

  • 1[1]Chertow G M,Leve E M,Hammermeister K E,et al.Independent association between acute renal failure and mortality following cardiac surgery[J].Am J Med,1998,104(4):343-348.
  • 2[2]Suen W S,Mok C K,Chiu S W,et al.Risk factors for development of aculte renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery[J].Angiology,1998,49 (10):789-800.
  • 3[3]Conlon P J,Stafford-Smith M,White W D,et al.Acute renal failure following cardiac surgery[J].Nephrol Dial Transplant,1999,14(5):1158-1162.
  • 4[4]Kramer P,Wigger W,Rieger J,et al.Arteriovenous hemofiltration:a new and simple method for treatment of over hydrated patients resistant to diuretics[J].Klin Wochenschr,1977,55(22):1121-1122.
  • 5[5]Mangano C M,Diamondstone L S,Ramsay J G,et al.Renal dysfunction after myocardial revascularization:risk factors,adverse outcomes,and hospital resource utilization.The multicenter study of perioperative ischemia researsh group[J].Ann Intern Med,1998,128(3):194-203.
  • 6[6]Dunham C M.Clinical impact of continuous renal replacement therapy on multiple organ failure[J].World J Surg,2001,25(5):669-676.
  • 7余晨,刘志红,郭啸华,陈朝红,季大玺,黎磊石.连续性血液净化治疗全身炎症反应综合征及脓毒症对机体免疫功能的影响[J].肾脏病与透析肾移植杂志,2003,12(1):2-9. 被引量:211
  • 8李振江,徐月清,王汉民,陈威.HV-CRRT对胰腺炎合并急性肾衰患者血中TNF-α的影响[J].细胞与分子免疫学杂志,2003,19(4):373-375. 被引量:8
  • 9刘宏宝,王汉民.炎性介质与SIRS、CARS、MODS和CBP治疗[J].国外医学(移植与血液净化分册),2004,2(2):4-7. 被引量:12
  • 10[10]Demirkilic U,Kuralay E,Yenicesu M,et al.Timing of replacement therapy for acute renal failure after cardiac surgery[J].J Card Surg,2004,19(1):17-20.

二级参考文献44

  • 1吴恒义,苏磊,宋新明,卢勇,白涛.创伤性成人呼吸窘迫综合征的诊治体会[J].中国危重病急救医学,1995,7(5):276-278. 被引量:26
  • 2王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1414
  • 3[1]Chertow GM,Levy EM,Hammermeister KE,et al.Independent association between acute renal failure and mortality following cardiac surgery.Am J Med,1998,104:343
  • 4[2]Suen WS,Mok CK,Chiu SW,et al.Risk factors for development of acute renal failure(ARF),requiring dialysis in patients under-going cardiac surgery.J Vasc Dis,1998,49(6):789
  • 5[3]Conlon PJ,Stafford Smith M,White WD,et al.Acute renal failure following cardiac surgery.Nephrol Dial Transplant,1999,14:1158
  • 6[4]Durmaz I,Buket S,Atay Y,et al.Cardiac surgery with cardiopulmonary bypass in patients with chronic renal failure.J Thorac Cardiovasc Surg,1999,118:306
  • 7[7]Knaus WA,Wagner DP,Draper EA,et al.The APACHE Ⅲ prognostic system:risk prediction of hospital mortality for critically ill hospitalized adults.Chest,1991,100(6):1619
  • 8[8]Cremer J,Martin M,Redl H,et al.Systemic inflammatory response syndrome after cardiac operations.Ann Thorac Surg,1996,61:1714
  • 9[9]Mangano CM,Diamondstone LS,Ramsay JG,et al.Renal dysfunction after myocardial revascularization: risk factors,adverse outcomes,and hospital resource utilization.The Multicenteer Study of Perioperative Ischemia Researsh Group.Ann Intern Med,1998,128:194
  • 10[10]Sablotzki A,Dehne MG,Friedrich I,et al.Different expression of cytokines in survivors and non-survivors from MODS following cardiovascular surgery. Eur J Med Res,2003,8(2):71

共引文献238

同被引文献16

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部